Analyst consensus rating
Elevance Health Analyst Rating: Buy
Direct answer
Elevance Health's consensus rating is Buy.
21 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $482.38.
Forecast evidence checked November 19, 2026.
Get free Elevance Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $387.12
- Average price target
- $482.38
- High price target
- $523.00
- Low price target
- $406.00
- Low target gap
- +4.9%
- Target upside
- +24.6%
- High target gap
- +35.1%
- Target range width
- 30.2%
- Consensus rating
- Buy
- Analysts
- 21
- Evidence date
- November 19, 2026
- Valid through
- November 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Elevance Health?
Elevance Health has a verified Buy consensus. The same dataset has an average price target of $482.38.
How far are Elevance Health's low and high targets from the recorded price?
The low target implies +4.9%, while the high target implies +35.1%.
How many analysts are included in Elevance Health's consensus?
The verified consensus includes 21 analysts.
How is Elevance Health's target upside or downside calculated?
The average target of $482.38 is divided by the recorded price of $387.12, then one is subtracted to produce +24.6%. This does not guarantee a future return.
When was Elevance Health's analyst forecast verified?
The data was verified on 2026-11-19. The dataset is valid through 2026-11-26.